Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus
✍ Scribed by Theodora E.M.S. de Vries–Sluijs; Jurriën G.P. Reijnders; Bettina E. Hansen; Hans L. Zaaijer; Jan M. Prins; Suzan D. Pas; Martin Schutten; Andy I.M. Hoepelman; Clemens Richter; Jan W. Mulder; Rob A. de Man; Harry L.A. Janssen; Marchina E. van der Ende
- Book ID
- 119761704
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 885 KB
- Volume
- 139
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Relatively little is known about the role of hepatitis B virus (HBV) genotype G (HBV/G) in patients co‐infected with human immunodeficiency virus (HIV) and HBV. This study examined the prevalence and association of HBV/G to liver fibrosis in co‐infected patients. HBV genotypes were dete
Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin
To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5